Core Insights - Marpai, Inc. has demonstrated significant positive momentum with a better-than-expected sales cycle for 2026 and the renewal of its network access agreement with Aetna [1][2][3] Group 1: Sales and Growth - The company reports a robust sales cycle, securing a volume of new clients for January 1, 2026, that surpasses internal expectations, reinforcing its path to scalable growth and previously guided profitability targets [2] - The success of the 2026 sales cycle, coupled with the renewal of the Aetna Signature Administrator network agreement, sets a strong foundation for the year ahead [5] Group 2: Network and Cost Management - Marpai has successfully renewed its agreement to access the Aetna Signature Administrator (ASA) PPO network, ensuring broad, national access to Aetna's extensive network of high-quality providers for its self-funded employer clients [3] - The introduction of the Aetna Faircost Optimizer as an integrated cost management tool will help plan sponsors manage out-of-network claims costs effectively, enhancing Marpai's ability to deliver superior cost containment [4] Group 3: Company Overview - Marpai, Inc. operates in the $150 billion TPA sector, serving self-funded employer health plans that represent over $1.5 trillion in annual claims [6] - The company focuses on delivering value-oriented health plan services and operates nationwide, offering access to leading provider networks including Aetna and Cigna [6]

Application Proof of The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. If an offer or an invitation is made to the public in Hong Kong in due course, prospective investors are reminded t ...

Core Insights - Safe Supply Streaming Co Ltd. has entered into an Exclusive Territory License and Commercial Agreement with Healthy Sprays LLC, granting Safe Supply exclusive Canadian rights to distribute Healthy Sprays' GLP-1 solutions [1][4][5] Company Overview - Safe Supply is focused on advancing innovation in healthcare and wellness through strategic partnerships and acquisitions, aiming to improve health outcomes and accessibility [13] - Healthy Sprays is a U.S.-based leader in non-injectable metabolic health solutions, utilizing proprietary sublingual spray technology for its product line [2][12] Licensing Agreement Details - The Licensing Agreement will commence in January 2026 for an initial five-year period, with provisions for extension [4] - Safe Supply will pay a one-time, non-refundable license fee of USD $250,000, along with royalties on Canadian gross sales and fixed-cost purchases of product packaging and delivery technology from Healthy Sprays [6][8] Market Positioning - The partnership is expected to enhance consumer accessibility to modern healthcare solutions in Canada, particularly for those seeking alternatives to injectable therapies [3][4] - With the exclusivity granted, Safe Supply is positioned to lead the market as GLP-1 solutions gain mainstream adoption in Canada [5] Financial Aspects - Safe Supply is proposing a non-brokered private placement of units at C$0.05 per unit, aiming for gross proceeds of up to C$500,000 to fund the licensing fee and related expenses [7][8] - The offering includes common shares and warrants, with potential finders' fees of up to 7% [8][10]

Core Insights - OneMedNet Corporation has received strong validation for its redesigned data exploration and cohort-building platform from customers and prospects at ISPOR Europe, showcasing its commercial relevance and competitive differentiation [2][3] - The platform, built on Palantir Foundry and AIP, allows research teams to determine cohort feasibility in minutes instead of weeks, enhancing accuracy and efficiency [3][4] Company Overview - OneMedNet operates the largest global live, regulatory-grade AI-ready Real-World Data (RWD) network, encompassing over 2,130 provider sites, 47+ million unique patient lives, and 186+ million clinical exams and images [2][4] - The company aims to revolutionize the use of Real-World Data, providing insights that drive innovation in drug development, medical devices, and AI applications [4][5] Technological Advancements - Key advancements of the new platform include significantly faster cohort feasibility, AI-driven natural-language search for complex discovery tasks, and real-time availability of longitudinal insights [7] - The platform supports subscription workflows, which is expected to contribute to recurring-revenue growth for the company [7]

Core Insights - HealthLynked Corp. has entered into a Capital Market Advisory Agreement with NE Holdings, LLC to support its strategic initiative to list on Nasdaq Capital markets in the first half of 2026 [1][2] - The advisory services will include corporate readiness, financial structuring, audit coordination, investment banking introductions, and governance development, which are essential for the Nasdaq listing roadmap [2][8] - The engagement is seen as a significant step in enhancing HealthLynked's market position and expanding its institutional recognition and long-term growth potential [4][5] Advisory Services Scope - NE Holdings will conduct a comprehensive due diligence and strategic review of HealthLynked's operations, structure, and financials [8] - A Nasdaq Listing Roadmap will be developed, including readiness planning, investor messaging, and compliance oversight [8] - The advisory will assist in optimizing capital structure to align with Nasdaq expectations and facilitate introductions to key market participants [8] Strategic Significance - The partnership with NE Holdings is expected to strengthen HealthLynked's market position and enhance its corporate foundation [4] - HealthLynked aims to transform healthcare through advanced connectivity, AI, and coordinated care management, positioning itself as a potential game changer in the industry [5] - The company's cloud-based platform connects patients with providers and consolidates medical records, improving healthcare outcomes and reducing costs [7]

We recently published 10 Stocks Beating Wall Street at its Own Game. Hinge Health Inc. (NYSE:HNGE) is one of the best-performing stocks on Wednesday. Hinge Health snapped a five-day losing streak on Wednesday, adding 8.57 percent to close at $44.10 apiece as investors cheered its higher growth outlook for full-year 2025 despite a mixed earnings performance in the third quarter. In a statement, Hinge Health Inc. (NYSE:HNGE) said it is increasing its revenue guidance to a range of $572 million to $574 mill ...

Core Insights - Nvidia is transforming healthcare through AI tools that enhance various hospital functions, including assisting surgeons and analyzing medical scans [1][2] - The company is addressing the projected shortage of 11 million healthcare workers by 2030, emphasizing the critical role of AI in meeting healthcare demands [2][4] AI Integration in Healthcare - Nvidia is collaborating with GE HealthCare to develop autonomous imaging technologies, aiming to improve access in underserved areas [5] - The company is also partnering with Moon Surgical to create a robotic assistant that can adjust surgical cameras in real time, marking a significant advancement in surgical assistance [5] - Additionally, Nvidia is working with Johnson & Johnson to simulate virtual operating room environments for robotic deployment [5] Enhancing Efficiency and Reducing Burnout - Delivery robots are being utilized to transport supplies, thereby reducing the workload for nurses [8] - Nvidia's technology supports software that helps doctors avoid burnout, such as a voice app that transcribes doctor-patient conversations into medical notes, saving approximately 30% of doctors' time [8][9] Advanced Diagnostic Tools - Aidoc's AI technology analyzes radiology images to expedite the detection of critical conditions like strokes, which is crucial for timely patient triage [11][12] - Nvidia's systems are designed with multiple safety layers to ensure reliability in medical applications [12] Future Vision of Healthcare - The envisioned future of hospitals includes an intelligent AI network that automates operations in real time, enhancing overall efficiency [15] - Nvidia emphasizes that AI is intended to assist healthcare professionals rather than replace them, maintaining human oversight in medical processes [15][16]

Core Insights - Clover Health Investments, Corp. will have its CFO, Peter Kuipers, present at the 2025 Citi Global Healthcare Conference on December 4, 2025 [1] Company Overview - Clover Health is a physician enablement technology company focused on providing access to quality healthcare for Medicare recipients, particularly seniors who have historically faced challenges in accessing affordable healthcare [2] - The company's strategy is driven by its software platform, Clover Assistant, which aggregates patient data to support clinical decision-making and improve health outcomes by identifying and managing chronic diseases early [2] - Clover Health offers PPO and HMO Medicare Advantage plans across several states, emphasizing its wide-network, high-choice PPO plans [2] - The company extends its data-driven technology platform to healthcare providers outside its Medicare Advantage plan through its subsidiary, Counterpart Health, aiming to enhance patient outcomes and reduce healthcare costs nationwide [2] - Clover Health has published data showcasing the technology's effectiveness in improving Medication Adherence, managing Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and addressing the needs of Underserved Populations, as well as in the early identification and management of Diabetes and Chronic Kidney Disease [2]

Company Information - Veri Medtech Holdings, Inc. has filed a registration statement on Form S-1 with the SEC for a proposed initial public offering of its Class A common stock, with the number of shares and price range yet to be determined [1] - The offering is subject to market conditions, and there is no assurance regarding the completion, size, or terms of the offering [1] - The proposed offering will be made only by means of a prospectus, and the registration statement has not yet become effective [2] Industry Overview - The global telemedicine market was valued at USD 114.98 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 17.96% from 2024 to 2030 [7] - Growth in the telemedicine market is driven by industry consolidation, strategic initiatives by key companies, and increasing healthcare consumerism [7] - Factors such as rising adoption of telemedicine by providers and increasing patient acceptance are expected to contribute to market growth [7]

Core Insights - Veradigm announced enhancements to its AI-enhanced Ambient Scribe solution for EHR customers, showcasing its commitment to advanced AI solutions that improve clinical documentation and patient care [1] Company Developments - The Ambient Scribe solution has evolved significantly since its launch last year, indicating robust development and integration of AI technologies in healthcare [1]